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Background: The ACTN3 gene may influence performance in team sports, in which sprint action and high-speed
movements, regulated by the anaerobic energy system, are crucial to the ultimate success of a match. The aim of
this study was to determine the association between the ACTN3 R577X (rs1815739) polymorphism and elite team
sport athletic status in Italian male athletes.
Methods: We compared the genotype and allele frequency of the ACTN3 R577X polymorphism between team
sport athletes (n = 75), endurance athletes (n = 40), sprint/power athletes (n = 64), and non-athletic healthy controls
(n = 192) from Italy. Genomic DNA was collected using a buccal swab. Extraction was performed according to the
manufacturer’s directions provided with a commercially available kit (Qiagen S.r.l., Milan, Italy).
Results: Team sport athletes showed a lower frequency of the 577RR genotype compared to the 577XX genotype
than sprint/power athletes (p = 0.044). However, the ACTN3 R577X polymorphism was not associated with team
sport athletic status compared to endurance athletes and non-athletic controls.
Conclusions: Our results agree with a recent large-scale study involving athletes from Spain, Poland, and Russia.
The ACTN3 R577X polymorphism was not associated with team sport athletic status compared to endurance
athletes and non-athletic controls.Key points
 The study showed that the ACTN3 R577X
polymorphism is not considered a candidate gene
to influence the performance of team sport
athletes, yet we confirmed that the ACTN3
577RR genotype is overrepresented in sprint/
power athletes compared to those in team
sports.
 As result, this study emphasizes the importance
of considering well-defined groups of athletes
with a clear reference phenotype in genetic
association studies applied to elite sport performance,
also suggesting possible inter-individual genetic
differences between athletes in the same team
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Research in the field of genetics among elite athletic per-
formers has focused primarily on the sport at the end
point of the sports performance continuum (sprint/
power vs. endurance performance), yet the type of sport
in which both the aerobic and anaerobic energy systems
are important for achieving a high level of performance,
such as team sports or endurance sports, has received
little attention.
One of the most common targets of investigation has
been a single nucleotide polymorphism (SNP) in the
ACTN3 gene, which encodes the alpha-actinin-3 protein
[1]. This polymorphism leads to a premature stop codon
(X), rather than an arginine (R) at position 577. Alpha-
actinin-3 deficiency (ACTN3 577XX genotype) occurs in
approximately 16% of the global population [1] and is
associated with variations in human muscle perform-
ance. The alpha-actinin-3 protein is almost exclusively
expressed in fast, glycolytic, and type IIX fibers that are
responsible for the generation of rapid forceful contractions
during activities such as sprinting.is an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Table 1 Genotype and allelic distribution and Hardy
Weinberg equilibrium (HWE) among athletes and controls.
Team sport Power Endurance Control
All (n) 74 64 40 190
XX 14% 6% 15% 12%
RX 54% 45% 55% 58%
RR 32% 49% 30% 30%
MAF 0.413 0.289 0.425 0.406
HWE p value 0.478 0.549 1.00 0.057
Elite (n) 28 43 15
XX 14% 7% 13%
RX 61% 35% 60%
RR 25% 58% 27%
MAF 0.446 0.250 0.433
National (n) 46 21 25
XX 15% 5% 20%
RX 50% 67% 40%
RR 35% 28% 40%
MAF 0.394 0.364 0.400
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erature regarding the influence of ACTN3 on athletic
performance suggest that the ACTN3 577RR genotype is
associated with sprint/power athletes among Caucasians.
Recently, Mikami et al. [5] examined a large cohort of elite
Japanese athletes (n = 299) and found that the ACTN3
R577X genotype was associated with sprint/power per-
formance among track and field competitors, especially
running 100- to 200-m sprints, and that R allele was asso-
ciated with relative peak power in male collegiate athletes
[6]. On the contrary, a recent study of Caucasian and East
Asian swimmers did not show an association between
ACTN3 polymorphism and elite swimmer status [7]. The
ACTN3 577X allele and the 577XX genotype were signifi-
cantly associated with only certain groups of elite endur-
ance athletes [8-17].
Seto et al. [18] provided a mechanistic explanation for
the effects of the ACTN3 genotype on skeletal muscle
performance in elite athletes and on adaptation to chan-
ging physical demands in the general population. The
authors highlighted the emerging evidence of the roles
of alpha-actinin-3 in the regulation of metabolic and sig-
naling pathways, contractile properties, and muscle fiber
type. They showed that alpha-actinin-3 deficiency re-
sulted in increased calcineurin activity in mouse and hu-
man skeletal muscle and an enhanced adaptive response
to endurance training. Only a few studies investigated
the association between the ACTN3 R577X polymorph-
ism and team sport performance. Santiago et al. [19]
examined the frequency of this ACTN3 genotype in 60
top-level professional Spanish soccer players, showing
that the percentage distributions of 577RR and 577RX
genotypes (48.3% and 36.7%) were significantly higher
and lower, respectively, than those in controls (n = 123;
28.5% and 53.7%) or endurance athletes (n = 52; 26.5%
and 52%) (p = 0.041). In a previous study [20], we did
not find a significant difference in top-level soccer
players’ (n = 42) jump performance among the various
genotypes.
Pimenta et al. [21] examined 200 Brazilian professional
soccer players and found that 577RR carriers ran 10, 20,
and 30 m faster than 577XX carriers. Furthermore, the
former scored higher in jump tests compared to both
577RX and 577XX carriers.
Not all the studies, however, found an association be-
tween ACTN3 R577X polymorphism and team sport
performance [22-24]. Recently, Garatachea et al. [25] did
not find an association between ACTN3 genotypes and
explosive leg power in elite basketball players or with
the status of being this type of athlete. Finally, Eynon
et al. [26] compared the genotype and allele frequencies
of the ACTN3 R577X polymorphisms in a relatively
large cohort of team sport athletes (n = 205), endurance
athletes (n = 305), sprint/power athletes (n = 378), andnon-athletic controls (n = 568) from Europe and found
that ACTN3 R577X polymorphism was not associated
with team sport athletic status. However, they did find
that the 577RR genotype was overrepresented in sprint/
power athletes compared to team sport athletes.
The aim of this study was to analyze the associations
between ACTN3 R577X polymorphisms and elite team
sport athletic status in a group of Italian athletes and to
compare their genotype distributions with elite sprint/
power athletes, endurance athletes, and non-athletic
controls.
Methods
A total of 178 Italian male athletes (n = 74 team sport
athletes, n = 64 sprint/power athletes, n = 40 endurance
athletes) and 190 controls were recruited between 2004
and 2014. All participants were unrelated European
men, and all had Caucasian lineage for at least three
generations. According to individual best performances,
the athletes were divided into two subgroups: ‘elite level’
(competitors in European/World Championships or in
the Olympic Games) and ‘national level’ (competitors
in national-level but not international-level events)
(Table 1). Of the athletes, 101 (57%) were classified as
elite level and the remaining 77 (43%) were classified
as national level.
(i) The team sport athletes (n = 74) included 64
soccer players and 10 hockey players. Of these,
8 hockey players competed at international level
Table 2 Odds ratios of genotypes for athletes and control








OR 1 1 1
RX
OR 0.72 0.99 0.50
CI 0.32 to 1.63 0.23 to 4.18 0.14 to 1.73
p 0.520 1 0.384
RR
OR 0.79 1.04 0.26
CI 0.33 to 1.89 0.21 to 4.98 0.07 to 0.95
p 0.654 1 0.044
RR and RX
(XX ref)
OR 0.75 1.01 0.38
CI 0.34 to 1.63 0.25 to 4.03 0.11 to 1.26
p 0.534 1 0.168
RR (RX and
XX ref)
OR 1.02 1.05 0.48
CI 0.57 to 1.83 0.35 to 3.08 0.23 to 0.96
p 1 1 0.053
OR, odds ratio; CI, confidence interval; p, two-tailed p value. Significance is assumed
when p< 0.05. The value in italics is statistically significant.
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players competed at international level
(including five World Championships), while 2
hockey players and 44 soccer players competed
at the national level (Italian Professional
Championships, ‘Serie A’).
(ii) The sprint/power athletes (n = 64) included 16 track
and field sprinters, 1 sprint swimmer, 17 wrestlers,
11 power lifters, and 19 gymnasts. Of these, 11
sprinters, 1 swimmer, 4 wrestlers, 10 power lifters,
and 17 gymnasts were in the elite-level group, while
5 sprinters, 13 wrestlers, 1 power lifter, and 2
gymnasts were in the national-level group.
(iii)The endurance athletes (n = 40) included 24 track
and field long-distance runners and 16 triathletes.
Of these, 15 triathletes were in the elite-level group
while all runners and 1 triathlete was in the
national-level group.
The genotype frequencies among these athletes were
compared with those of the randomly selected healthy
non-athletic Italian males (controls). The controls were
selected if they did not participate regularly in any com-
petitive or structured sport or physical activity.
All participants and their parent/guardian (for minors)
provided written informed consent, and the study proto-
col and informed written consent procedure were ap-
proved by the Medical Ethics Committees of the Italian
Sports Federations, in accordance with Declaration
of Helsinki for Human Research of 1974 (last modified
in 2000).
Genomic DNA was extracted from each athlete with a
buccal swab during the years 2004 to 2014, according to
the manufacturer’s directions provided with a commer-
cially available kit (Qiagen S.r.l., Milan, Italy) [27]. Exon
16 of ACTN3 was amplified through polymerase chain
reaction using the following primers:
forward 5′-CTGTTGCCTGTGGTAAGTGGG-3′
reverse 5′-TGGTCACAGTATGCAGGAGGG-3′.
Polymerase chain reaction products were digested with
DdeI enzyme. The 577R and 577X alleles (CGA and
TGA codons, respectively) were distinguished by the
presence (577X) or absence (577R) of a DdeI restriction
site in exon 16. Allele 577X shows two fragments with
205 and 85 bp, while allele 557R presents three frag-
ments with 108, 97, and 86 bp. The obtained fragments
were separated by 10% polyacrylamide gel electrophor-
esis and stained with ethidium bromide [27]. To ensure
proper internal control, for each genotype analysis, we
used positive and negative controls from different DNA
aliquots that were previously genotyped with the same
method.
Chi-squared tests were used to test for the presence
of Hardy-Weinberg equilibrium (HWE). Multinomiallogistic regression analyses were conducted to assess
the association between genotype and athletic status/
competition level. In each case, analyses were made
comparing 577XX (reference group) vs. 577RX, 577XX
vs. 577RR (co-dominant effect), 577XX vs. 577RR and
577RX combined (dominant effect), and 577XX and
577RX combined (reference group) vs. 577RR (reces-
sive effect). Significance was accepted when p ≤ 0.05.
Chi-squared tests for HWE were conducted using
Genepop (v. 9), while statistical analyses were con-
ducted using STATISTICA (Statsoft v. 7)
Results
Table 1 shows the genotype and allele frequency distri-
butions in the non-athletes and athletes divided by
group and subgroup. The genotype distributions met
HWE (all p > 0.05) for all groups of participants.
Our data showed significant differences in genotype
frequency between team sport athletes and sprinters
(Table 2). Team sport athletes had a lower frequency of
the 577RR genotype compared to the 577XX genotype
than the sprint/power athletes (p = 0.044) (Table 2). In
fact, the sprint/power athletes were approximately 1.5
times more likely to have the 577RR genotype (as
opposed to the 577XX genotype) than team sport
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notypes with respect to the level of competition (elite vs.
national level) (Table 3).
Discussion
We tested, for the first time, the association between
ACTN3 R577X polymorphism and team sport
athletic status in Italian athletes. Our results indicate
that team sport athletes have a lower 577RR than
577XX genotype frequency, compared to sprint/power
athletes (p = 0.044). No significant difference in the
ACTN3 R577X polymorphism genotype distribution
was found between the team sport athletes, endurance
athletes, and control group. Furthermore, the ACTN3
R577X genotype distribution was similar between
elite-level and national-level team sport athletes, sug-
gesting that this polymorphism is not influential among
team sport athletes.
Our findings agree with those of Eynon et al. [26],
who recently analyzed elite team sport athletes from
three European countries (i.e., Spain, Poland, and Russia)
and showed that their performance was not significantly
influenced by ACTN3 R577X polymorphism. Similarly,
our results agree with theirs in that team sport athletes
were less likely to possess the 577RR genotype than the
577XX genotype compared to power athletes (p = 0.045).
The ACTN3 R577X polymorphism was consistently
associated with elite sprint/power status [2,3] and muscle
power [6]. The functional consequence of the ACTN3
R577X polymorphisms on sport performance is supported
by the Actn3 knock-out (KO) mouse model [28]. The
authors demonstrated that the loss of alpha-actinin ex-
pression results in a shift in muscle metabolism toward
the more efficient aerobic pathway, with a subsequent
increase in running distance achieved before exhaustion
during a treadmill test [28]. Moreover, the Actn3 KO
mice (ACTN3 577XX), compared to wild-type (WT)
counterparts, had lower muscle mass (smaller diameter
fast-twitch muscle fibers), significantly lesser grip strength,
significantly lower anaerobic enzyme activity, and higher
oxidative/mitochondrial enzyme activity without a shift
in fiber-type distribution [29].Table 3 Odds ratios of genotypes for elite athletes




RX 1.293 0.32 to 5.13 1
RR 0.765 0.16 to 3.48 1
RX-RR (XX ref) 1.076 0.28 to 4.07 1
RR (XX-RX ref) 0.625 0.21 to 1.78 0.444
CI, confidence interval; ref, reference; OR, odds ratio.In team sports, most of the decisive actions during
competition are characterized by jumping and/or
sprinting, and it is for that reason that we hypothesized
that the 577RR genotype would be associated with
team sport performance. However, team sports gener-
ally involve mixed aerobic-anaerobic demands and
players may not need to have extraordinary aerobic/an-
aerobic capacity. During a soccer game, for example,
aerobic metabolism dominates energy delivery [30], yet
the most decisive actions, characterized by jumping
and sprinting, are supported by anaerobic metabolism.
In similar team sports, many factors contribute to
success, including muscle power, aerobic endurance,
ball skills, and psychological traits. Therefore, muscle
power represents just one of several factors that deter-
mine a player’s ability but a substantial development of
this factor is decisive during the crucial phases of a
match.
When studying the possible role of genetics in team
sports, it should be noted that not all players have similar
characteristics in terms of physiological demand because
it varies based on the position played. For example, during
a rugby match, players perform various activities based on
their position [31]. Forwards, rather than backs, are in-
volved in significantly more physical collisions and tackles,
experience a greater proportion of high-intensity activity
than low-intensity activity, and travel greater distances
during a match (9,929 vs. 8458 m) [31], demonstrating
that a wide range of skills and physiological demands exist
for the different playing positions.
Indeed, while ACTN3 R577X polymorphism has
been previously associated with sprint/power or en-
durance performance, the results of this study sug-
gest that it is not associated with team sport athletic
status.
The most obvious limitation of this study is the sample
size. However, the very large population samples required
to reach a sufficient statistical power in the field of genetic
studies do not harmonize with the limited number of elite
athletes for each sport discipline. We believe that the
small sample size could be justifiable by the number of
top-level athletes and by the homogeneity of the sample
in terms of geographical and ethnical origin, recruited
for the present study.
Conclusions
In conclusion, our results confirm, for the Italian popu-
lation, the recent data published by Eynon et al. [26] that
ACTN3 R577X polymorphism is not significantly associ-
ated with team sport athletic status, when team sport
athletes are compared to endurance athletes and non-
athletic controls, and the 577RR genotype is overrepre-
sented in power/sprint athletes compared to team sport
athletes.
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